List of Tables
Table 1 Neuromodulation Devices Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 2 Scs Number of Units, Based on Region, (2021-2029) (No's)
Table 3 Dbs Number of Units, Based on Region, (2021-2029) (No's)
Table 4 Sns Number of Units, Based on Region, (2021-2029) (No's)
Table 5 Vns Number of Units, Based on Region, (2021-2029) (No's)
Table 6 Hgns Number of Units, Based on Region, (2021-2029) (No's)
Table 7 Neuromodulation Devices Global Market Revenue, Based on Product, (2021-2029) ($Mn)
Table 8 Neuromodulation Devices Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 9 Invasive Neuromodulation Devices Global Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 10 Invasive Neuromodulation Devices Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 11 Spinal Cord Stimulation (Scs) Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 12 Deep Brain Stimulation (Dbs) Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 13 Sacral Nerve Stimulation (Sns) Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 14 Vagus Nerve Stimulation (Vns) Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 16 Other Invasive Neuromodulation Devices Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 17 Non-Invasive Neuromodulation Devices Global Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 18 Non-Invasive Neuromodulation Devices Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 19 Transcutaneous Electrical Nerve Stimulation (Tens) Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 20 Neuromuscular Electrical Stimulation (Nmes) Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 21 Other Non-Invasive Neuromodulation Devices Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 22 Neuromodulation Devices Global Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 23 Pain Management Global Market Revenue, Based on Application Type, (2021-2029) ($Mn)
Table 24 Pain Management Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 25 Chronic Pain Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 26 Failed Back Surgery Syndrome (Fbss) Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 27 Other Pain Management Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 28 Central Nervous System (Cns) Global Market Revenue, Based on Application Type, (2021-2029) ($Mn)
Table 29 Central Nervous System (Cns) Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 30 Parkinson's Disease Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 31 Dystonia Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 32 Epilepsy Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 33 Others Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 34 Gastroenterology and Urology Global Market Revenue, Based on Application Type, (2021-2029) ($Mn)
Table 35 Gastroenterology and Urology Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 36 Gastroparesis Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 37 Urinary Incontinence Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 38 Faecal Incontinence Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 39 Obstructive Sleep Apnea Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 40 Other Applications Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 41 Neuromodulation Devices Global Market Revenue, Based on End-Users, (2021-2029) ($Mn)
Table 42 Hospitals and Ambulatory Surgery Centers (Asc) Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 43 Clinics and Physiotherapy Centers Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 44 Others Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 45 Neuromodulation Devices Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 46 North America Neuromodulation Devices Market Revenue, Based on Product, (2021-2029) ($Mn)
Table 47 North America Invasive Neuromodulation Devices Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 48 North America Non-Invasive Neuromodulation Devices Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 49 North America Neuromodulation Devices Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 50 North America Pain Management Market Revenue, Based on Application Type, (2021-2029) ($Mn)
Table 51 North America Central Nervous System Market Revenue, Based on Application Type, (2021-2029) ($Mn)
Table 52 North America Gastroenterology and Urology Market Revenue, Based on Application Type, (2021-2029) ($Mn)
Table 53 North America Neuromodulation Devices Market Revenue, Based on End-Users, (2021-2029) ($Mn)
Table 54 North America Neuromodulation Devices Market Revenue, Based on Country, (2021-2029) ($Mn)
Table 55 United States Neuromodulation Devices Global Market Revenue, Based on Products (2022) ($ Mn)
Table 56 Rest of North America Neuromodulation Devices Global Market Revenue, Based on Products (2022) ($ Mn)
Table 57 Europe Neuromodulation Devices Market Revenue, Based on Product, (2021-2029) ($Mn)
Table 58 Europe Invasive Neuromodulation Devices Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 59 Europe Non-Invasive Neuromodulation Devices Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 60 Europe Neuromodulation Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 61 Europe Pain Management Market Revenue, Based on Application Type, (2021-2029) ($Mn)
Table 62 Europe Central Nervous System Market Revenue, Based on Application Type, (2021-2029) ($Mn)
Table 63 Europe Gastroenterology and Urology Market Revenue, Based on Application Type, (2021-2029) ($Mn)
Table 64 Europe Neuromodulation Devices Market Revenue, Based on End-Users, (2021-2029) ($Mn)
Table 65 Europe Neuromodulation Devices Market Revenue, Based on Country, (2021-2029) ($Mn)
Table 66 Germany Neuromodulation Devices Global Market Revenue, Based on Products (2022) ($ Mn)
Table 67 France Neuromodulation Devices Global Market Revenue, Based on Products (2022) ($ Mn)
Table 68 United Kingdom Neuromodulation Devices Global Market Revenue, Based on Products (2022) ($ Mn)
Table 69 Rest of Europe Neuromodulation Devices Global Market Revenue, Based on Products (2022) ($ Mn)
Table 70 APAC Neuromodulation Devices Market Revenue, Based on Product, (2021-2029) ($Mn)
Table 71 APAC Invasive Neuromodulation Devices Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 72 APAC Non-Invasive Neuromodulation Devices Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 73 APAC Neuromodulation Devices Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 74 APAC Pain Management Market Revenue, Based on Application Type, (2021-2029) ($Mn)
Table 75 APAC Central Nervous System Market Revenue, Based on Application Type, (2021-2029) ($Mn)
Table 76 APAC Gastroenterology and Urology Market Revenue, Based on Application Type, (2021-2029) ($Mn)
Table 77 APAC Neuromodulation Devices Market Revenue, Based on End-Users, (2021-2029) ($Mn)
Table 78 APAC Neuromodulation Devices Market Revenue, Based on Country, (2021-2029) ($Mn)
Table 79 Japan Neuromodulation Devices Global Market Revenue, Based on Products (2022) ($ Mn)
Table 80 China Neuromodulation Devices Global Market Revenue, Based on Products (2022) ($ Mn)
Table 81 India Neuromodulation Devices Global Market Revenue, Based on Products (2022) ($ Mn)
Table 82 Rest of APAC Neuromodulation Devices Global Market Revenue, Based on Products (2022) ($ Mn)
Table 83 Row Neuromodulation Devices Market Revenue, Based on Product, (2021-2029) ($Mn)
Table 84 Row Invasive Neuromodulation Devices Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 85 Row Non-Invasive Neuromodulation Devices Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 86 Row Neuromodulation Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 87 Row Pain Management Market Revenue, Based on Application Type, (2021-2029) ($Mn)
Table 88 Row Central Nervous System Market Revenue, Based on Application Type, (2021-2029) ($Mn)
Table 89 Row Gastroenterology and Urology Marketrevenue, Based on Application Type, (2021-2029) ($Mn)
Table 90 Row Neuromodulation Devices Market Revenue, Based on End-Users, (2021-2029) ($Mn)
Table 91 Row Neuromodulation Devices Market Revenue, Based on Country, (2021-2029) ($Mn)
Table 92 Brazil Neuromodulation Devices Global Market Revenue, Based on Products (2022) ($ Mn)
Table 93 Rest of Latam Neuromodulation Devices Global Market Revenue, Based on Products (2022) ($ Mn)
Table 94 Middle East and Others Neuromodulation Devices Global Market Revenue, Based on Products (2022) ($ Mn)
Table 95 Product Approval (2020-2022)
Table 96 Product Launch (2020-2022)
Table 97 Agreement and Collaboration (2020-2022)
Table 98 Agreement and Collaboration (2020-2022)
Table 99 Other Dvelopments (2020-2022)
Table 100 Abbott Laboratories.: Total Revenue and R&D Expenses, (2020-2022)(Q3) ($Mn)
Table 101 Abbott Laboratories.: Total Revenue, Based on Segment, (2020-2022)(Q3) ($Mn)
Table 102 Abbott Laboratories.: Total Revenue, Based on Sub-Segment, (2020-2022)(Q3) ($Mn)
Table 103 Abbott Laboratories.: Total Revenue, Based on Geography, (2020-2022)(Q3) ($Mn)
Table 104 Axonics Inc.: Total Revenue and R&D Expenses (2020-2022 (Q3) ($Mn)
Table 105 Axonics Inc.: Total Revenue, Based on Segment, (2020-2022 (Q3) ($Mn)
Table 106 Axonics Inc.: Total Revenue, Based on Region, (2020-2022 (Q3) ($Mn)
Table 107 Bioventus.: Total Revenue and R&D Expenses (2020-2022 (Q3) ($Mn)
Table 108 Bioventus.: Total Revenue, Based on Segment, (2020-2022 (Q3) ($Mn)
Table 109 Bioventus.: Total Revenue, Based on Region, (2020-2022 (Q3) ($Mn)
Table 110 Boston Scientific Corporation : Total Revenue and R&D Expenses, (2020-2022 (Q3) ($Mn)
Table 111 Boston Scientific Corporation: Total Revenue, Based on Segment, (2020-2022 (Q3) ($Mn)
Table 112 Boston Scientific Corporation: Total Revenue, Based on Med Surg Sub - Segment, (2020-2022 (Q3) ($Mn)
Table 113 Boston Scientific Corporation: Total Revenue, Based on Geography, (2020-202 (Q3) ($Mn)
Table 114 Inspire Medical System, Inc.: Total Revenue and R&D Expenses, (2020-2022 (Q3) ($Mn)
Table 115 Inspire Medical System,Inc.: Total Revenue, Based on Geography, (2020-2022) (Q3) ($Mn)
Table 116 Livanova plc.: Total Revenue and R&D Expenses, (2020-2022 (Q3) ($Mn)
Table 117 Livanova plc.: Total Revenue, Based on Segment, (2020-2022 (Q3) ($Mn)
Table 118 Livanova plc.: Total Revenue, Based on Geography, (2020-2022 (Q3) ($Mn)
Table 119 Medtronic, plc: Total Revenue and R&D Expenses, (2020-2022)(Q2) ($Mn)
Table 120 Medtronic, plc: Total Revenue, Based on Segments, (2020-2022)(Q2) ($Mn)
Table 121 Medtronic, plc: Neuromodulation Total Revenue, Based on Sub-Segments, (2022-2022)(Q2) ($Mn)
Table 122 Medtronic, plc: Total Revenue, Based on Geography, (2021-2023)(Q2) ($Mn)
Table 123 Neuropace, Inc.: Total Revenue and R&D Expenses, (2020-2022 (Q3) ($Mn)
Table 124 Nevro Corporation : Total Revenue and R&D Expenses (2020-2022 (Q3) ($Mn)
Table 125 Nevro Corporation: Total Revenue, Based on Geography, (2020-2022 (Q3) ($Mn)
List of Figures
Figure 1 Neuromodulation Devices Global Market Revenue, Based on Region (2021-2029) ($Mn)
Figure 2 Research Methodology: Neuromodulation Devices Global Market
Figure 3 Neuromodulation Devices Global Market: Top-Down and Bottom-Up Approach
Figure 4 Neuromodulation Devices Global Market: Forecasting Model
Figure 5 Neuromodulation Devices Global Market: Market Breakdown and Data Triangulation
Figure 6 Neuromodulation Devices Global Market Segmentation
Figure 7 Market Dynamics
Figure 8 Neuromodulation Devices Clinical Trial Analysis
Figure 9 Neuromodulation Devices Clinical Trial Analysis
Figure 10 Neuromodulation Devices Clinical Trial Analysis
Figure 11 Neuromodulation Devices Global Market: Porter's Analysis
Figure 12 Neuromodulation Devices: Supply Chain Analysis
Figure 13 Neuromodulation Devices Global Market Share Analysis, Based on Key Players, 2022 (%)
Figure 14 Spinal Cord Stimulator (Scs) Global Market Share Analysis, Based on Key Players, 2022 (%)
Figure 15 Deep Brain Stimulator (Dbs) Global Market Share Analysis, Based on Key Players, 2022 (%)
Figure 16 Sacral Nerve Stimulator (Sns) Global Market Share Analysis, Based on Key Players, 2022 (%)
Figure 17 Hypoglossal Nerve Stimulator (Hgns) Global Market Share Analysis, Based on Key Players, 2022 (%)
Figure 18 United States Obstructive Sleep Apnea Neuromodulation Devices Market Penetration, 2022 (%)
Figure 19 United States Drug Resistant Epilepsy Neuromodulation Devices Market Penetration, 2022 (%)
Figure 20 United States Depression Neuromodulation Devices Market Penetration, 2022 (%)
Figure 21 United States Overactive Bladder Neuromodulation Devices Market Penetration, 2022 (%)
Figure 22 United States Chronic Pain Neuromodulation Devices Market Penetration, 2022 (%)
Figure 23 U.S. Bat Market Penetration, Opportunity and Number of Procedures Performed, (2022)
Figure 24 E.U. Countries Bat Market Penetration, Opportunity and Number of Procedures Performed, (2022)
Figure 25 5 APAC Countries Bat Market Penetration, and Opportunity, (2022)
Figure 26 Neuromodulation Devices Global Market Share, Based on Product (2022 V/S 2029) (%)
Figure 27 Invasive Neuromodulation Devices Global Market Share, Based on Product Type (2022 V/S 2029) (%)
Figure 28 Spinal Cord Stimulation (Scs) Global Market Revenue, Based on Country (2022) ($ Mn)
Figure 29 Deep Brain Stimulation (Dbs) Global Market Revenue, Based on Country (2022) ($ Mn)
Figure 30 Sacral Nerve Stimulation (Sns) Global Market Revenue, Based on Country (2022) ($ Mn)
Figure 31 Vagus Nerve Stimulation (Vns) Global Market Revenue, Based on Country (2022) ($ Mn)
Figure 32 Hypoglossal Nerve Stimulation (Hgns) Global Market Revenue, Based on Country (2022) ($ Mn)
Figure 33 Other Invasive Neuromodulation Global Market Revenue, Based on Country (2022) ($ Mn)
Figure 34 Non-Invasive Neuromodulation Devices Global Market Share, Based on Product Type, (2022 V/S 2029) (%)
Figure 35 Transcutaneous Electrical Nerve Stimulation (Tens) Global Market Revenue, Based on Country (2022) ($ Mn)
Figure 36 Neuromuscular Electrical Stimulation (Nmes) Global Market Revenue, Based on Country (2022) ($ Mn)
Figure 37 Other Non-Invasive Neuromodulation Devices Global Market Revenue, Based on Country (2022) ($ Mn)
Figure 38 Neuromodulation Devices Global Market Share, Based on Application (2022 V/S 2029) (%)
Figure 39 Pain Management Global Market Share, Based on Application Type (2022 V/S 2029) (%)
Figure 40 Central Nervous System (Cns) Global Market Share, Based on Application Type, (2022 V/S 2029) (%)
Figure 41 Gastroenterology and Urology Global Market Share, Based on Application Type, (2022 V/S 2029) (%)
Figure 42 Neuromodulation Devices Global Market Share, Based on End-Users (2022 V/S 2029) (%)
Figure 43 Neuromodulation Devices Global Market Revenue, Based on Region (2021-2029) ($Mn), CAGR (%)
Figure 44 Neuromodulation Devices Global Market Share, Based on Geography (2022) (%), Country ($Mn)
Figure 45 North America Neuromodulation Devices Market Share, Based on Products, (2022 V/S 2029) (%)
Figure 46 North America Invasive Neuromodulation Devices Market Share, Based on Product Type (2022 V/S 2029) (%)
Figure 47 North America Non-Invasive Neuromodulation Devices Market Share, Based on Product Type (2022 V/S 2029) (%)
Figure 48 North America Neuromodulation Devices Market Share, Based on Application (2022 V/S 2029) (%)
Figure 49 North America Pain Management Market Share, Based on Application Type (2022 V/S 2029) (%)
Figure 50 North America Central Nervous System Market Share, Based on Application Type (2022 V/S 2029) (%)
Figure 51 North America Gastroenterology/Urology Market Share, Based on Application Type (2022 V/S 2029) (%)
Figure 52 North America Neuromodulation Devices Market Share, Based on End-user (2022 V/S 2029) (%)
Figure 53 North America Neuromodulation Devices Market, Based on Country (2022 V/S 2029) (%)
Figure 54 U.S. Neuromodulation Devices Market Revenue, Based on Products and Applications (2022 V/S 2029) ($Mn)
Figure 55 U.S. Neuromodulation Devices Market Revenue, Based on End-users (2022 V/S 2029) ($Mn)
Figure 56 Rest of North America Neuromodulation Devices Market Revenue, Based on Products and Applications (2022 V/S 2029) ($Mn)
Figure 57 Rest of North America Neuromodulation Devices Market Revenue, Based on End-users (2022 V/S 2029) ($Mn)
Figure 58 Europe Neuromodulation Devices Market Share, Based on Product, (2022 V/S 2029) (%)
Figure 59 Europe Invasive Neuromodulation Devices Market Share, Based on Product Type (2022 V/S 2029) (%)
Figure 60 Europe Non-Invasive Neuromodulation Devices Market Share, Based on Product Type (2022 V/S 2029) (%)
Figure 61 Europe Neuromodulation Devices Market Share, Based on Application (2022 V/S 2029) (%)
Figure 62 Europe Pain Management Market Revenue, Based on Application Type (2022 V/S 2029) (%)
Figure 63 Europe Central Nervous System Market Share, Based on Application Type (2022 V/S 2029) (%)
Figure 64 Europe Gastroenterology/Urology Market Share, Based on Application Type (2022 V/S 2029) (%)
Figure 65 Europe Neuromodulation Devices Market Share, Based on End-users (2022 V/S 2029) (%)
Figure 66 Europe Neuromodulation Devices Market Share, Based on Country (2022 V/S 2029) (%)
Figure 67 Germany Neuromodulation Devices Market Revenue, Based on Products and Applications (2022 V/S 2029) ($Mn)
Figure 68 Germany Neuromodulation Devices Market Revenue, Based on End-Users (2022 V/S 2029) ($Mn)
Figure 69 France Neuromodulation Devices Market Revenue, Based on Products and Applications (2022 V/S 2029) ($Mn)
Figure 70 France Neuromodulation Devices Market Revenue, Based on End-users (2022 V/S 2029) ($Mn)
Figure 71 U.K. Neuromodulation Devices Market Revenue, Based on Products and Applications (2022 V/S 2029)($Mn)
Figure 72 U.K. Neuromodulation Devices Market Revenue, Based on End-users (2022 V/S 2029) ($Mn)
Figure 73 Rest of Europe Neuromodulation Devices Market Revenue,Based on Product and Application (2022 V/S 2029) ($Mn)
Figure 74 Rest of Europe Neuromodulation Devices Market Revenue, Based on End-user (2022 V/S 2029) (%)
Figure 75 APAC Neuromodulation Devices Market Share, Based on Product, (2022 V/S 2029) (%)
Figure 76 APAC Invasive Neuromodulation Devices Market Share, Based on Product Type (2022 V/S 2029) (%)
Figure 77 APAC Non-Invasive Neuromodulation Devices Market Share, Based on Product Type (2022 V/S 2029) (%)
Figure 78 APAC Neuromodulation Devices Market Share, Based on Application (2022 V/S 2029) (%)
Figure 79 APAC Pain Management Market Share, Based on Application Type (2022 V/S 2029) (%)
Figure 80 APAC Central Nervous System Market Share, Based on Application Type (2022 V/S 2029) (%)
Figure 81 APAC Gastroenterology/Urology Market Share, Based on Application Type (2022 V/S 2029) (%)
Figure 82 APAC Gastroenterology/Urology Market Share, Based on End-users (2022 V/S 2029) (%)
Figure 83 APAC Neuromodulation Devices Market Share, Based on Country (2022 V/S 2029) (%)
Figure 84 Japan Neuromodulation Devices Market Revenue, Based on Product and Application (2022 V/S 2029) ($Mn)
Figure 85 Japan Neuromodulation Devices Market Revenue, Based on End-user (2022 V/S 2029) ($Mn)
Figure 86 China Neuromodulation Devices Market Revenue, Based on Products and Applications (2022 V/S 2029) ($Mn)
Figure 87 China Neuromodulation Devices Market Revenue, Based on End-users (2022 V/S 2029) ($Mn)
Figure 88 India Neuromodulation Devices Market Revenue, Based on Products and Applications (2022 V/S 2029) ($Mn)
Figure 89 India Neuromodulation Devices Market Revenue, Based on End-users (2022 V/S 2029) ($Mn)
Figure 90 Rest of APAC Neuromodulation Devices Market Revenue, Based on Product and Application (2022 V/S 2029) ($Mn)
Figure 91 Rest of APAC Neuromodulation Devices Market Revenue, Based on End-user (2022 V/S 2029) ($Mn)
Figure 92 Row Neuromodulation Devices Market Share, Based on Product (2022 V/S 2029) (%)
Figure 93 Row Invasive Neuromodulation Devices Market Share, Based on Product Type (2022 V/S 2029) (%)
Figure 94 Row Non-Invasive Neuromodulation Devices Market Share, Based on Product Type (2022 V/S 2029) (%)
Figure 95 Row Neuromodulation Devices Market Share, Based on Application (2022 V/S 2029) (%)
Figure 96 Row Pain Management Market Share, Based on Application Type (2022 V/S 2029) (%)
Figure 97 Row Central Nervous System Market Share, Based on Application Type (2022 V/S 2029) (%)
Figure 98 Row Gastroenterology/Urology Market Share, Based on Application Type (2022 V/S 2029) (%)
Figure 99 Row Neuromodulation Devices Market Share, Based on End-user (2022 V/S 2029) (%)
Figure 100 Row Neuromodulation Devices Market Share, Based on Country (2022 V/S 2029) (%)
Figure 101 Brazil Neuromodulation Devices Market Revenue, Based on Products and Applications (2022 V/S 2029) ($Mn)
Figure 102 Brazil Neuromodulation Devices Market Revenue, Based on End-users (2022 V/S 2029) ($Mn)
Figure 103 Rest of Latam Neuromodulation Devices Market Revenue, Based on Product and Application (2022 V/S 2029) ($Mn)
Figure 104 Rest of Latam Neuromodulation Devices Market Revenue, Based on End-user (2022 V/S 2029) ($Mn)
Figure 105 Middle East and Others Neuromodulation Devices Market Revenue, Based on Product and Application (2022 V/S 2029) ($Mn)
Figure 106 Middle East and Others Neuromodulation Devices Market Revenue, Based on End-user (2022 V/S 2029) ($Mn)
Figure 107 Key Growth Strategies, (2020-2022)
Figure 108 SWOT: Abbott Laboratories
Figure 109 SWOT: Axonics Inc.
Figure 110 SWOT: BioventUS
Figure 111 SWOT: Boston Scientific Corporation
Figure 112 SWOT: Inspire Medical System, Inc.
Figure 113 SWOT: Laborie Medical Technology Inc.
Figure 114 SWOT: Livanova plc
Figure 115 SWOT: Medtronic plc.
Figure 116 SWOT: Neuropace, Inc.
Figure 117 SWOT: Nevro Corporation